Skip to content

Kao Corporation: Regarding Shareholder Statement

By API User

TOKYO–BUSINESS WIRE– Oasis Management Company Ltd. (hereinafter referred to as “Oasis Management”), an investment management firm and a shareholder of our company, released a statement regarding Director candidates to be proposed at our 119th Ordinary General Meeting of Shareholders. Kao’s Board of Directors and management team strive to increase shareholder value from a long-term perspective … Continued

Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas

By API User

Six Late-Stage Programs with Peak Revenue Potential of $10B – $20B1 Poised to Deliver Sustainable Growth Expected Phase 3 Data Readouts in 2025 for Oveporexton (TAK-861), Zasocitinib (TAK-279) and Rusfertide (TAK-121) Regulatory Filings for Oveporexton (Narcolepsy Type 1), Zasocitinib (Psoriasis) and Rusfertide (Polycythemia Vera) on Track for Fiscal Years 2025 – 2026 Five Additional Filings … Continued

CHA Welcomes move to Pricing Benchmarks in Aged Care

By API User

Catholic Health Australia (CHA) has welcomed the Government’s decision to support more flexible pricing to deliver high quality aged care services in the home as part of the Support at Home program which begins on 1 July 2025.   “By using pricing benchmarks instead of pricing caps, the sector can focus on delivering high quality … Continued

ARS Pharmaceuticals Announces Filings for Approval of neffy® in China, Japan and Australia

By API User

Licensing partners in key Asia Pacific countries have filed for approval of neffy (epinephrine nasal spray) 2 mg with regulatory agencies SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to … Continued

St Vincent’s Private Hospitals nurses and midwives to start daily rolling stop works across all shifts

By API User

Friday 13 December 2024 Hundreds of St Vincent’s Private Hospitals nurses and midwives will start daily rolling stop work protected industrial action across the morning, afternoon and night shifts from 7am, Friday 13 December. The ANMF has over 1000 members in a St Vincent’s Private nursing and midwifery workforce of around 1400. Theatre and recovery … Continued

Why copper could be key to treating a rare childhood cancer

By API User

The survival rate for children with a rare but deadly cancer could one day be improved by adding an existing drug – which is currently used to manage excess copper in the body – to their treatment.  The drug can be used to weaken tumours and strengthen the fighting capacity of immune cells, increasing the … Continued

CIL Announces Breakthrough in Benzene Recovery, Addressing Cost, Environmental, and Supply Challenges for OLED Display Manufacturers

By API User

TEWKSBURY, MA / ACCESSWIRE / December 12, 2024 / Cambridge Isotope Laboratories, Inc. (CIL) has successfully developed and implemented a game-changing benzene-d6 recovery program, addressing major pain points for manufacturers of organic light-emitting diode (OLED) displays. This innovative service reduces costs, minimizes environmental impact, and conserves scarce deuterium supplies. OLED display producers rely heavily on … Continued

Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Through Partnership With Agenus

By API User

  CHARLOTTE, N.C. & LEXINGTON, Mass.–BUSINESS WIRE– Tanner Pharma, a global provider of specialty medicine access solutions, today announced a collaboration with Agenus, a leading immuno-oncology company, to provide expanded access to botensilimab (BOT) and balstilimab (BAL). Through a Named Patient Program (NPP), this initiative offers patients with microsatellite stable colorectal cancer (MSS CRC) and … Continued

Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engineering and Development for Drug Discovery Applications

By API User

New Kits Capture Full-Length BCR Sequences from Mouse Samples, Enhancing their Utility for Immunological Studies SEATTLE–BUSINESS WIRE– Parse Biosciences, a leader in scalable single cell sequencing solutions, today announced the expansion of its Evercode BCR™ product line to enable applications in mice. The new kits enable researchers to profile the mouse BCR repertoire alongside whole … Continued